130 related articles for article (PubMed ID: 11360750)
21. Volumetric quantification of the effect of aging and hormone replacement therapy on breast composition from digital mammograms.
Hammann-Kloss JS; Bick U; Fallenberg E; Engelken F
Eur J Radiol; 2014 Jul; 83(7):1092-1097. PubMed ID: 24788077
[TBL] [Abstract][Full Text] [Related]
22. Hormone replacement therapy and screening mammography: analysis of the results in the Bouches du Rhône programme.
Séradour B; Estève J; Heid P; Jacquemier J
J Med Screen; 1999; 6(2):99-102. PubMed ID: 10444729
[TBL] [Abstract][Full Text] [Related]
23. Hormone replacement therapy and mammographic screening.
Evans A
Clin Radiol; 2002 Jul; 57(7):563-4. PubMed ID: 12096852
[TBL] [Abstract][Full Text] [Related]
24. Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review.
Banks E
J Med Screen; 2001; 8(1):29-34. PubMed ID: 11373847
[TBL] [Abstract][Full Text] [Related]
25. Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006.
Séradour B; Allemand H; Weill A; Ricordeau P
Bull Cancer; 2009 Apr; 96(4):E1-6. PubMed ID: 19435691
[TBL] [Abstract][Full Text] [Related]
26. Decreasing rate of fatty involution at screening mammography.
Blane CE; Fitzgerald JT; Gruppen LD; Oh MS; Helvie MA; Andersson I
Acad Radiol; 2002 Aug; 9(8):895-8. PubMed ID: 12186437
[TBL] [Abstract][Full Text] [Related]
27. Correlates of mammogram density in southwestern Native-American women.
Roubidoux MA; Kaur JS; Griffith KA; Sloan J; Wilson C; Novotny P; Lobell M
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):552-8. PubMed ID: 12815002
[TBL] [Abstract][Full Text] [Related]
28. Use and cost of breast imaging for postmenopausal women undergoing hormone replacement therapy.
Harvey JA
AJR Am J Roentgenol; 1999 Jun; 172(6):1615-9. PubMed ID: 10350301
[TBL] [Abstract][Full Text] [Related]
29. [Mammography changes associated with hormone replacement therapy in post-menopausal patients].
Del Favero C; Rossini G; Tufarulo L; Ciancio ML; Sopransi M; Martegani A; Borghi C; Campi R; Fugazzola C
Radiol Med; 1997 Mar; 93(3):210-3. PubMed ID: 9221411
[TBL] [Abstract][Full Text] [Related]
30. Evaluating hormone therapy-associated increases in breast density comparison between reported and simultaneous assignment of BI-RADS categories, visual assessment, and quantitative analysis.
Harvey JA; Bovbjerg VE; Smolkin ME; Williams MB; Petroni GR
Acad Radiol; 2005 Jul; 12(7):853-62. PubMed ID: 16039539
[TBL] [Abstract][Full Text] [Related]
31. Mammographic breast density changes after 1 year of tibolone use.
Kutlu T; Fiçicioğlu C; Başaran T; Başaran E; Topaloğlu T
Maturitas; 2004 Jun; 48(2):133-6. PubMed ID: 15172087
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for breast cancer in women undergoing mammography.
Reuter KL; Baker SP; Krolikowski FJ
AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
[TBL] [Abstract][Full Text] [Related]
33. The influence of HRT on technical recall in the UK Breast Screening Programme: are pain, compression force, and compressed breast thickness contributing factors?
Nimmo LJ; Alston LA; McFadyen AK
Clin Radiol; 2007 May; 62(5):439-46. PubMed ID: 17398269
[TBL] [Abstract][Full Text] [Related]
34. Reproductive and hormonal factors associated with mammographic breast density by age (United States).
El-Bastawissi AY; White E; Mandelson MT; Taplin SH
Cancer Causes Control; 2000 Dec; 11(10):955-63. PubMed ID: 11142530
[TBL] [Abstract][Full Text] [Related]
35. Mammographic density in women on postmenopausal hormone replacement therapy.
Leung W; Goldberg F; Zee B; Sterns E
Surgery; 1997 Oct; 122(4):669-73; discussion 673-4. PubMed ID: 9347841
[TBL] [Abstract][Full Text] [Related]
36. The effect of hormone replacement therapy on the sensitivity of screening mammograms.
Litherland JC; Stallard S; Hole D; Cordiner C
Clin Radiol; 1999 May; 54(5):285-8. PubMed ID: 10362232
[TBL] [Abstract][Full Text] [Related]
37. A comparison of different methods for including 'age at menopause' in analyses of the association between hormone replacement therapy use and breast cancer.
Simpson JA; English DR; Macinnis RJ; Gertig DM; Hopper JL; Giles GG
J Fam Plann Reprod Health Care; 2007 Jan; 33(1):11-6. PubMed ID: 17389089
[TBL] [Abstract][Full Text] [Related]
38. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
39. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy).
Tzingounis V; Cardamakis E; Ginopoulos P; Argiropoulos G
Anticancer Res; 1996; 16(6C):3997-4000. PubMed ID: 9042326
[TBL] [Abstract][Full Text] [Related]
40. Hormone replacement therapy and breast density changes.
Harvey J; Scheurer C; Kawakami FT; Quebe-Fehling E; de Palacios PI; Ragavan VV
Climacteric; 2005 Jun; 8(2):185-92. PubMed ID: 16096175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
